The CMIL team presented eight posters covering histopathological image analysis, drug treatment response in lupus nephritis, detection and scoring of microvascular inflammation in kidney allografts, and single-cell molecular characterization of neovascularization in chronic kidney disease. One of our works by Luis on “Integrating Pathomic and Clinical Data Using Artificial Intelligence (AI) Models from Kidney Deceased Donors to Reduce Organ Discard and Improve Transplant Outcomes” was selected for an oral presentation.
Dr. Sarder served as a session moderator, providing updates on cutting-edge techniques and accomplishments from scientists at the forefront of basic science in diabetic kidney disease. He presented a talk on the role of generative AI in pathology and participated as a panelist, where he discussed the potential of AI to identify new disease mechanisms and therapeutic targets.